Public Sector Pension Investment Board Uni Qure N.V. Transaction History

Public Sector Pension Investment Board

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$11.12 - $22.2 $20,805 - $41,536	1,871 Added 2.58%	74,327 $851,000
Q1 2023 May 12, 2023	SELL	$18.7 - $23.07 $54,622 - $67,387	-2,921 Reduced 3.88%	72,456 $1.46 Million
Q3 2022 Nov 14, 2022	BUY	$16.98 - $25.54 $134,600 - $202,455	7,927 Added 11.75%	75,377 $1.41 Million
Q1 2022 May 13, 2022	SELL	$14.54 - $21.5 $86,513 - $127,925	-5,950 Reduced 8.11%	67,450 $1.22 Million
Q4 2021 Feb 14, 2022	SELL	$20.24 - $36.01 $38,921 - $69,247	-1,923 Reduced 2.55%	73,400 $1.52 Million
Q3 2021 Nov 12, 2021	BUY	$26.01 - $38.22 $1.96 Million - $2.88 Million	75,323 New	75,323 $2.41 Million

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Public Sector Pension Investment Board, based on Form 13F filings with the SEC.

Stay updated on Public Sector Pension Investment Board with notifications on news.